KLEMA CATHY
CIK: 0001181157
Primary company: PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI)
KLEMA CATHY is a corporate insider at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) filing SEC Form 4 transactions. 97 transactions across 4 companies, totaling $0 in purchases and $3,433,877 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
OptimizeRx Corp OPRX | Award | 34,517 | - | - | 56,137 | 6/9/2026 Filed: 6/9/2026 | Filing → |
OptimizeRx Corp OPRX | Award | 9,868 | - | - | 21,620 | 6/11/2025 Filed: 6/12/2025 | Filing → |
OptimizeRx Corp OPRX | Exercise | 5,109 | - | - | 0 | 2/2/2025 Filed: 2/4/2025 | Filing → |
OptimizeRx Corp OPRX | Exercise | 5,109 | - | - | 11,752 | 2/2/2025 Filed: 2/4/2025 | Filing → |
OptimizeRx Corp OPRX | Award | 6,643 | - | - | 6,643 | 6/7/2024 Filed: 6/11/2024 | Filing → |
OptimizeRx Corp OPRX | Award | 5,109 | - | - | 5,109 | 2/2/2024 Filed: 2/6/2024 | Filing → |
Allergan plc AGN | Tax Payment | 953 | $147.00 | $140K | 25,081 | 4/30/2019 Filed: 5/2/2019 | Filing → |
Allergan plc AGN | J | 410 | $0.00 | $0 | 26,034 | 3/11/2019 Filed: 3/13/2019 | Filing → |
Allergan plc AGN | Award | 1,985 | $151.07 | $300K | 25,624 | 5/2/2018 Filed: 5/4/2018 | Filing → |
Allergan plc AGN | Award | 1,223 | $245.25 | $300K | 23,639 | 5/4/2017 Filed: 5/5/2017 | Filing → |
Allergan plc AGN | Award | 201 | $248.31 | $50K | 22,416 | 8/8/2016 Filed: 8/9/2016 | Filing → |
Allergan plc AGN | Award | 1,188 | $210.34 | $250K | 22,215 | 5/5/2016 Filed: 5/9/2016 | Filing → |
Allergan plc AGN | Award | 826 | $302.30 | $250K | 21,027 | 6/5/2015 Filed: 6/30/2015 | Filing → |
Allergan plc AGN | Tax Payment | 549 | $303.38 | $167K | 20,201 | 6/4/2015 Filed: 6/30/2015 | Filing → |
Actavis plc ACT | Award | 826 | $302.30 | $250K | 21,027 | 6/5/2015 Filed: 6/8/2015 | Filing → |
Actavis plc ACT | Tax Payment | 549 | $303.38 | $167K | 20,201 | 6/4/2015 Filed: 6/8/2015 | Filing → |
Actavis plc ACT | Award | 1,142 | $197.05 | $225K | 20,750 | 5/9/2014 Filed: 5/13/2014 | Filing → |
Actavis plc ACT | Award | 19,608 | - | - | 19,608 | 10/1/2013 Filed: 10/3/2013 | Filing → |
| Disposition | 19,608 | - | - | 0 | 10/1/2013 Filed: 10/2/2013 | Filing → | |
| Sale | 1,667 | $133.03 | $222K | 19,608 | 8/12/2013 Filed: 8/14/2013 | Filing → |
OptimizeRx Corp
OPRX
Type
Award
Shares
34,517
Price
-
Value
-
OptimizeRx Corp
OPRX
Type
Award
Shares
9,868
Price
-
Value
-
OptimizeRx Corp
OPRX
Type
Exercise
Shares
5,109
Price
-
Value
-
OptimizeRx Corp
OPRX
Type
Exercise
Shares
5,109
Price
-
Value
-
OptimizeRx Corp
OPRX
Type
Award
Shares
6,643
Price
-
Value
-
OptimizeRx Corp
OPRX
Type
Award
Shares
5,109
Price
-
Value
-
Allergan plc
AGN
Type
Tax Payment
Shares
953
Price
$147.00
Value
$140K
Allergan plc
AGN
Type
J
Shares
410
Price
$0.00
Value
$0
Allergan plc
AGN
Type
Award
Shares
1,985
Price
$151.07
Value
$300K
Allergan plc
AGN
Type
Award
Shares
1,223
Price
$245.25
Value
$300K
Allergan plc
AGN
Type
Award
Shares
201
Price
$248.31
Value
$50K
Allergan plc
AGN
Type
Award
Shares
1,188
Price
$210.34
Value
$250K
Allergan plc
AGN
Type
Award
Shares
826
Price
$302.30
Value
$250K
Allergan plc
AGN
Type
Tax Payment
Shares
549
Price
$303.38
Value
$167K
Actavis plc
ACT
Type
Award
Shares
826
Price
$302.30
Value
$250K
Actavis plc
ACT
Type
Tax Payment
Shares
549
Price
$303.38
Value
$167K
Actavis plc
ACT
Type
Award
Shares
1,142
Price
$197.05
Value
$225K
Actavis plc
ACT
Type
Award
Shares
19,608
Price
-
Value
-
Type
Disposition
Shares
19,608
Price
-
Value
-
Type
Sale
Shares
1,667
Price
$133.03
Value
$222K
AI Agent
Try asking...